CERS

NASD Cerus Corporation

Nov 5, 2026 · 10:48 AM ET DELAYED Market Open

$2.20 ↓ -0.22 (-8.90%) Trading Down from the previous close of $2.42, $0.24 below the day’s high of $2.44

YTD change: +6.80%
vs 20-day SMA: -5.10%
vs 200-day SMA: -10.05%

Price ranges

Previous day

$2.32 $2.52

open $2.39 close $2.42

+$0.02 (+1.05%)

Today

$2.20 $2.44

open $2.43 now $2.20

-$0.23 (-9.47%)

Past week

$2.11 $2.52

from $2.42 now $2.20

-$0.22 (-9.09%)

Past month

$2.11 $2.52

from $2.29 now $2.20

-$0.09 (-3.93%)

This year

$1.62 $3.47

from $2.06 now $2.20

+$0.14 (+6.80%)

Price & Performance

-0.17 (-6.76%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good

The stock is 75.2% away from all-time highs of $8.87
CERS is up 7% since the beginning of the year
CERS is up 52% over the past 12 months
CERS is down 4% over the past 1 month
9% of all CERS investors are betting against CERS

CERS reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +66.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A

EPS N/A

Earnings momentum +100.0% Quarterly EPS growth

Quarterly change +100.0%

Valuation

P/E ratio N/A

Enterprise value $505.5M

Beta 2.77

Balance sheet & scale

IncomeN/A

Revenue$226.6M

Cash$57.1M

Debt$75.0K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $444.3M

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Competitor comparison

Ticker	Company	Price	Change
CSLLY	CSL Limited Sponsored ADR	$35.10	+1.33%
ARGX	argenx SE Sponsored ADR	$931.38	+3.36%
ONC	BeOne Medicines Ltd. Sponsored ADR	$377.78	+6.42%
WXXWY	WuXi Biologics (Cayman) Inc. Unsponsored ADR	$12.48	+13.45%
INCY	Incyte Corporation	$122.85	+4.47%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.